2021
Reopening Schools After a Novel Coronavirus Surge
Li D, Lin EZ, Brault MA, Paquette J, Vermund SH, Godri Pollitt KJ. Reopening Schools After a Novel Coronavirus Surge. Advances In Experimental Medicine And Biology 2021, 1318: 785-813. PMID: 33973212, DOI: 10.1007/978-3-030-63761-3_44.Peer-Reviewed Original ResearchConceptsCoronavirus disease 2019 (COVID-19) pandemicDisease 2019 pandemicGlobal death tollMental health supportPandemic influenzaDisease controlHealth supportSocial isolationNew guidelinesVulnerability of childrenRisk reductionRiskDisease control strategiesSafetyChild safetySpecial considerationDeath tollOpening schoolsPandemic
2017
Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China
Lou J, Hu P, Qian HZ, Ruan Y, Jin Z, Xing H, Shao Y, Vermund SH. Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China. PLOS ONE 2017, 12: e0171295. PMID: 28406992, PMCID: PMC5390964, DOI: 10.1371/journal.pone.0171295.Peer-Reviewed Original ResearchConceptsCondom use increasesNew HIV infectionsMale sexual partnersPartner reductionCondom useSexual partnersHIV infectionBeijing MSMHIV new infectionsSexual behavioral changesAntiretroviral treatmentHIV testingHIV incidenceHIV prevalenceCombination interventionsSubstantial additional benefitNew infectionsUse increasesSexual networksInfectionMSMMenRisk reductionBehavioral changesTreatment
2013
High HIV Incidence among Persons Who Inject Drugs in Pakistan: Greater Risk with Needle Sharing and Injecting Frequently among the Homeless
Samo RN, Altaf A, Agha A, Pasha O, Rozi S, Memon A, Azam S, Blevins M, Vermund SH, Shah SA. High HIV Incidence among Persons Who Inject Drugs in Pakistan: Greater Risk with Needle Sharing and Injecting Frequently among the Homeless. PLOS ONE 2013, 8: e81715. PMID: 24358123, PMCID: PMC3864804, DOI: 10.1371/journal.pone.0081715.Peer-Reviewed Original ResearchConceptsIncidence of HIVHIV seroconversionIncidence rateMultivariable Cox regression analysisNeedle/syringe exchangeCohort of PWIDHIV-seronegative personsHigh HIV incidenceOpiate substitution therapyCox regression analysisHIV incidence ratesHIV risk reductionSharing of syringesRisk reductionSubstance abuse treatmentSeronegative personsCohort studyRisk reduction programsHIV incidencePerson yearsSubstitution therapyDaily injectionsNeedle sharingRisk factorsPrevalence ratesTranslation of Biomedical Prevention Strategies for HIV
Vermund SH, Tique JA, Cassell HM, Pask ME, Ciampa PJ, Audet CM. Translation of Biomedical Prevention Strategies for HIV. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2013, 63: s12-s25. PMID: 23673881, PMCID: PMC3725750, DOI: 10.1097/qai.0b013e31829202a2.Peer-Reviewed Original ResearchConceptsPrevention of motherPrevention strategiesClean injection equipmentChild HIV transmissionBiomedical approachBiomedical prevention strategiesRisk of acquisitionHIV prevention strategiesBehavioral risk reductionHigh-prevalence regionsRisk of transmissionCircumcision of menBlood product safetyChild transmissionHIV transmissionAntiretroviral drugsPrevalence regionsHIV preventionHIVFamily planningMore childrenPreventionRisk reductionInjection equipmentSaharan Africa
2010
Combination HIV Prevention: Significance, Challenges, and Opportunities
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV Prevention: Significance, Challenges, and Opportunities. Current HIV/AIDS Reports 2010, 8: 62-72. PMID: 20941553, PMCID: PMC3036787, DOI: 10.1007/s11904-010-0063-3.Peer-Reviewed Original ResearchConceptsHIV prevention strategiesHIV transmissionPrevention strategiesPopulation-level HIV transmissionBehavioral risk reductionEvidence-based strategiesNumber of interventionsAntiretroviral medicationsHIV serostatusPrevention packageUninfected personsEpidemiologic profileHIV pandemicMale circumcisionNeedle exchangeEffective interventionsTarget populationInterventionRisk reductionMeasurable reductionPopulation levelDiverse subgroupsMedicationsSerostatusHIV
2009
Preventing HIV in Developing Countries: Status of Biomedical Interventions
Vermund S. Preventing HIV in Developing Countries: Status of Biomedical Interventions. The FASEB Journal 2009, 23: 199.1-199.1. DOI: 10.1096/fasebj.23.1_supplement.199.1.Peer-Reviewed Original ResearchHIV Prevention Trials NetworkPrevention of motherHIV drug resistanceNeedle exchange programsDNA boostBehavior changeHIV seroconversionHIV seroincidenceEarly therapyPregnant womenHSV-2Clinical trialsHIVMale circumcisionDrug addiction treatmentDrug resistanceTrials NetworkAddiction treatmentBiomedical interventionsSeroincidenceInfantsRisk reductionTherapyPrevention challengesEfficacy
2001
Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study
Vermund S, Wilson C, Rogers A, Partlow C, Moscicki A. Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study. Journal Of Adolescent Health 2001, 29: 49-56. PMID: 11530303, DOI: 10.1016/s1054-139x(01)00296-8.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusUninfected youthHigh STI ratesSexual risk profilesBaseline prevalence dataHigher infection rateImmunodeficiency virusREACH studySTI ratesAdolescent careHigh-risk youthInfection ratePrevalence dataRisk profileHealth ProjectCross-sectional dataSpecimen collectionRisk reductionLongitudinal analysisInfectionReviewSTIsBaselineCareLaboratory analysis
2000
Network-related Mechanisms May Help Explain Long-term HIV-1 Seroprevalence Levels That Remain High but Do Not Approach Population-Group Saturation
Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des Jarlais DC. Network-related Mechanisms May Help Explain Long-term HIV-1 Seroprevalence Levels That Remain High but Do Not Approach Population-Group Saturation. American Journal Of Epidemiology 2000, 152: 913-922. PMID: 11092433, DOI: 10.1093/aje/152.10.913.Peer-Reviewed Original ResearchConceptsDrug injectorsSeroprevalence levelsHIV-1 incidenceHigh-risk subgroupsHuman immunodeficiency virusBehavioral risk reductionHigh prevalence situationsImmunodeficiency virusHigh seroprevalenceSeronegativesPrevention programsRisk behaviorsInfection outbreaksSeroprevalenceInfectious outbreaksMaximum incidenceSecondary outbreaksNetwork-based mechanismsRisk reductionIncidenceOutbreakOutbreak increasesNew York CityPrevalenceYork City